Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

Lancet

Volumn 351, Issue 9117, 1998, Pages 1682-1686

  Li, T S ^a   Tubiana, R ^a   Katlama, C ^a   Calvez, V ^a   Mohand, H Ait ^a   Autran, Brigitte ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; TUBERCULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD;

EID: 0032490305     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)10291-4     Document Type: Article

References (20)

1. 1 Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in patients with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337: 725-33.
2. 2 Gulick RM, Mellors JW, Havlir D, et al. Treatment of indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior anteretroviral therapy. N Engl J Med 1997; 337: 734-39.
3. 3 Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir zidovudine and zalcitabine. N Engl J Med 1996; 334: 1011-17.
4. 4 Mathez D, Bagnarelli P, Gorin I, et al. Reduction in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine, zalcitabine triple therapy. Antiviral Ther 1997; 2: 175-83.
5. 5 Perelson AS, Essunger P, Cao YZ, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387: 188-91.
6. 6 Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349: 1294.
7. 7 Reed JB, Schwab IR, Gordon J, et al. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997; 124: 199-205.
8. 8 Dolan MJ, Clerici M, Blatt SP, et al. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995; 172: 79-87.
9. 9 Giorgi JV, Fahey JL, Smith DC, et al. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987; 138: 3725-30.
10. 10 Hoy JF, Lewis DE, Miller GG. Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: a prospective study of in vitro response to Cryptococcus neoformans. J Infect Dis 1988; 158: 1971-78.
11. 11 Lane HC, Masur H, Gelmann EP, et al. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med 1985; 78: 417-22.
12. 12 Connors M, Kovacs JA, Krevat S, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletion within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997; 3: 533-40.
13. 13 Rinaldo C, Huang XL, Piazza P, et al. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. J Infect Dis 1991; 164: 638-45.
14. 14 Clerici M, Landay AL, Kessler HA, et al. Reconstitution of long term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients. J Infect Dis 1992; 166: 723-30.
15. 15 French MAH, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV+ infected patients. AIDS 1992; 6: 1293-97.
16. 16 Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, Ritonavir. J Infect Dis 1996; 173: 321-29.
17. 17 Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112-16.
18. 18 Emery S, Lane HC. Immune reconstitution in HIV infection. Curr Opin Immunol 1997; 9: 568-72.
19. 19 Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349: 1443-45.
20. 20 Gorochov G, Neumann AU, Kereveur A, et al. Perturbation of CD4 and CD8 T-cell repertoire during progression to AIDS and stabilization of the CD4 repertoire during anti-viral therapy. Nat Med 1998; 4: 215-21.